Búsqueda | Biblioteca Virtual en Salud

RSS XML

Resultados 1 - 3 de 3

1 Próxima > >>

Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).

Ueno, Asami; Onishi, Yasuhiro; Mise, Koki; Yamaguchi, Satoshi; Kanno, Ayaka; Nojima, Ichiro; Higuchi, Chigusa; Uchida, Haruhito A; Shikata, Kenichi; Miyamoto, Satoshi; Nakatsuka, Atsuko; Eguchi, Jun; Hida, Kazuyuki; Katayama, Akihiro; Watanabe, Mayu; Nakato, Tatsuaki; Tone, Atsuhito; Teshigawara, Sanae; Matsuoka, Takashi; Kamei, Shinji; Murakami, Kazutoshi; Shimizu, Ikki; Miyashita, Katsuhito; Ando, Shinichiro; Nunoue, Tomokazu; Wada, Jun.

BMJ Open Diabetes Res Care ; 12(3)2024 May 30.

Artículo en Inglés | MEDLINE | ID: mdl-38816205

Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2).

Mise, Koki; Imamura, Mariko; Yamaguchi, Satoshi; Watanabe, Mayu; Higuchi, Chigusa; Katayama, Akihiro; Miyamoto, Satoshi; Uchida, Haruhito A; Nakatsuka, Atsuko; Eguchi, Jun; Hida, Kazuyuki; Nakato, Tatsuaki; Tone, Atsuhito; Teshigawara, Sanae; Matsuoka, Takashi; Kamei, Shinji; Murakami, Kazutoshi; Shimizu, Ikki; Miyashita, Katsuhiro; Ando, Shinichiro; Nunoue, Tomokazu; Yoshida, Michihiro; Yamada, Masao; Shikata, Kenichi; Wada, Jun.

Front Cardiovasc Med ; 8: 668059, 2021.

Artículo en Inglés | MEDLINE | ID: mdl-34109226

Levee system along the upper Mississippi River

Nakato, Tatsuaki; Johnson, Shirley; Johnson, Dan; Jones, Donna.

In. <The> Committee of International Workshop on Floodplain Risk Management. Proceedings of international workshop on floodplain risk management. Hiroshima, <The> Committee of International Workshop on Floodplain Risk Management, 1996. p.107-20, mapas, tab.

Monografía en En | Desastres | ID: des-10132

Resultados 1 - 3 de 3

1 Próxima > >>

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).

Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2).

Levee system along the upper Mississippi River